COMMUNIQUÉS West-GlobeNewswire

Inventiva publie ses résultats financiers préliminaires pour l'exercice fiscal 2024¹ et fait le point sur son activité

10/02/2025 - 22:00

Chiffre d'affaires de 9,2 millions d'euros pour l’année 2024 Trésorerie et équivalents de trésorerie à 96,6 millions d’euros au 31 décembre 2024 Levée de la première tranche d'un financement structuré d'un montant [...]

Inventiva reports preliminary 2024 fiscal year financial results¹ and provides a business update

10/02/2025 - 22:00

Revenues of €9.2 million for the full year of 2024 Cash and cash equivalents at €96.6 million as of December 31, 2024 First tranche of up to €348 million structured financing closed with aggregate gross proceeds of €116 [...]

Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 Outlook

10/02/2025 - 22:02

Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024 MINNEAPOLIS, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire [...]

Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

10/02/2025 - 22:03

BOSTON, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by [...]

Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update

10/02/2025 - 22:05

Revenues increased 34% compared to the previous quarter ended September 30, 2024; and exceeded $1 million Received CE Mark for LungFit PH ® in Europe and Market Authorization in Australia; international shipments to [...]

PetMeds® Announces Third Quarter Fiscal 2025 Financial Results

10/02/2025 - 22:05

DELRAY BEACH, Fla., Feb. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its third quarter ended December 31, 2024. [...]

Stryker announces Allan Golston will retire from Board of Directors

10/02/2025 - 22:05

Portage, Michigan, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that after 14 years of distinguished service, Allan Golston has notified the company that he will not stand for re-election at [...]

Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10/02/2025 - 22:44

SAN DIEGO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on February 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock [...]

RxTechExam and Pennsylvania Pharmacists Association Join Forces to Launch Technician Training Program Ahead of Regulatory Changes

10/02/2025 - 22:44

HARRISBURG, Pa., Feb. 10, 2025 (GLOBE NEWSWIRE) -- RxTechExam and the Pennsylvania Pharmacists Association (PPA) have announced a strategic partnership aimed at addressing upcoming pharmacy technician regulations in [...]

Alumis to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

10/02/2025 - 22:45

SOUTH SAN FRANCISCO, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes [...]

EYLEA HD® (aflibercept) Injection 8 mg Positive Phase 3 Results in Patients with Macular Edema following Retinal Vein Occlusion Presented at Angiogenesis Meeting

08/02/2025 - 23:40

EYLEA HD led to improved vision with extended dosing intervals, achieving non-inferior vision gains with an every 8-week dosing regimen compared to EYLEA® (aflibercept) Injection 2 mg dosed every 4 weeks TARRYTOWN, N.Y [...]

Saudi Arabia’s KFSHRC Continues to Rise as a Globally Renowned Medical Centre

09/02/2025 - 12:08

RIYADH, Saudi Arabia, Feb. 09, 2025 (GLOBE NEWSWIRE) -- Saudi Arabia’s King Faisal Specialist Hospital & Research Centre (KFSHRC) – the region’s top-ranked hospital – has secured 15th place in 2025 among the world’s [...]

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

08/02/2025 - 00:35

ZUG, Switzerland, Feb. 08, 2025 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting of earnout shares and associated removal of restrictions on these ordinary shares. Attachments Notification of [...]

MEDIA ADVISORY: Public healthcare advocates to protest at Minister of Health Sylvia Jones’ office

08/02/2025 - 02:09

SITUATION CRITICAL TORONTO, Feb. 07, 2025 (GLOBE NEWSWIRE) -- On Saturday February 8 th at 12 noon, the Grey Bruce, Brampton Caledon and Greater Toronto health coalitions, local chapters of the Ontario Health Coalition [...]

REPEAT - MEDIA ADVISORY: Public healthcare advocates to protest at Minister of Health Sylvia Jones’ office

08/02/2025 - 14:00

SITUATION CRITICAL TORONTO, Feb. 08, 2025 (GLOBE NEWSWIRE) -- On Saturday February 8 th at 12 noon, the Grey Bruce, Brampton Caledon and Greater Toronto health coalitions, local chapters of the Ontario Health Coalition [...]

4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program

08/02/2025 - 20:30

3E10 vg/eye achieved an 83% reduction in injection burden vs. projected on-label aflibercept 2 mg Q8W, 70% required 0-1 supplemental injection, and 57% were injection-free through 52 weeks In the recently diagnosed [...]

Three-Year Results for EYLEA HD® (aflibercept) Injection 8 mg in Patients with Wet Age-related Macular Degeneration Demonstrate Continued Durable Vision Gains and Anatomic Improvements with Extended Dosing Intervals

08/02/2025 - 21:55

At three years of EYLEA HD treatment, the vast majority of patients maintained visual and anatomic improvements while achieving extended dosing regimens, including those of just twice a year : 77%, 58%, 40% and 24% [...]

Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics

07/02/2025 - 13:30

- University of Waterloo’s Faculty of Engineering Recognizes Dr. Wilson with Faculty Research Excellence Award - - Esteemed researchers and engineers like Dr. Wilson are currently helping Firefly lay the groundwork for [...]

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

07/02/2025 - 13:30

SAN DIEGO, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of [...]